CINQAIR (Reslizumab)

**Product type:** Human Prescription Drug

**Active ingredient:** RESLIZUMAB

**Strength:** 10 mg/mL

**Dosage form:** Injection, Solution, Concentrate

**Route:** Intravenous

**Labeler:** Teva Respiratory, LLC

**Marketing category:** BLA (BLA761033)

**Pharmacologic class:** Interleukin-5 Antagonist [EPC], Interleukin-5 Antagonists [MoA]